Monoclonal Antibodies Production Platforms: An Opportunity Study of a Non‐Protein‐A Chromatographic Platform Based on Process Economics
Monoclonal antibodies currently dominate the biopharmaceutical market with growing sales having reached 80 billion USD in 2016. As most top‐selling mAbs are approaching the end of their patent life, biopharmaceutical companies compete fiercely in the biosimilars market. These two factors present a s...
Gespeichert in:
Veröffentlicht in: | Biotechnology journal 2017-12, Vol.12 (12), p.n/a |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!